Eisele Jeffrey

EDGAR CIK 0001827326

Apellis Pharmaceuticals, Inc. - APLS

Officer
Chief Development Officer
Direct Buys
0
$0
0 Shares
Direct Sells
8
($1.04) M
-16,183 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
01/30/2024
10b5-1
01/31/2024
Sell
-971 @ $65.53
($63,630) 57,208 (-1.67%) Direct
01/29/2024
01/31/2024
Sell
-279 @ $64.14
($17,895) 58,179 (-0.48%) Direct
01/23/2024
10b5-1
01/24/2024
Sell
-7,378 @ $63.69
($469,905) 58,458 (-11.21%) Direct
01/22/2024
01/23/2024
Sell
-1,607 @ $65.00
($104,449) 65,836 (-2.38%) Direct
01/17/2024
10b5-1
01/18/2024
Sell
-5,207 @ $65.58
($341,475) 67,443 (-7.17%) Direct
01/16/2024
01/17/2024
Sell
-438 @ $66.81
($29,262) 72,650 (-0.60%) Direct
12/27/2023
10b5-1
12/28/2023
Sell
-235 @ $60.23
($14,154) 53,580 (-0.44%) Direct
12/26/2023
12/28/2023
Sell
-68 @ $57.86
($3,935) 53,815 (-0.13%) Direct